ArticleBMC gastroenterology2022

Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failure.

Yajuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.